Medical AI - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510246395

Publication Date:

October 25, 2024

Pages:

127

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

The purpose of the study is to enable the reader to gain a holistic view of the global AI in healthcare market, by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global AI in healthcare market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers integrated devices, software, and services related to AI in healthcare.
The global market for Medical AI was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical AI, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical AI by region & country, by Type, and by Application.
The Medical AI market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical AI.
Market Segmentation
By Company
Activ Surgical, Inc.
Atomwise, Inc.
Babylon Health
BenevolentAI
Butterfly Network, Inc.
Freenome
General Electric Company
International Business Machines Corporation (IBM)
Koninklijke Philips N.V.
Nuance Communications, Inc.
Nvidia Corporation
Olive
Siemens Healthineers AG
Viz.ai, Inc.
Zebra Medical Vision Ltd
Segment by Type:
AI-Integrated Hardware
Software
Services
Segment by Application
Medical Imaging and Diagnosis
Data Management
Telemedicine
Remote Monitoring and Lifestyle Management
Robot-Assisted Surgery
Drug Discover and Clinical Trials
Virtual Assistance
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical AI manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical AI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical AI in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Medical AI Product Introduction
1.2 Global Medical AI Market Size Forecast
1.3 Medical AI Market Trends & Drivers
1.3.1 Medical AI Industry Trends
1.3.2 Medical AI Market Drivers & Opportunity
1.3.3 Medical AI Market Challenges
1.3.4 Medical AI Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical AI Players Revenue Ranking (2023)
2.2 Global Medical AI Revenue by Company (2019-2024)
2.3 Key Companies Medical AI Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical AI Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical AI
2.6 Medical AI Market Competitive Analysis
2.6.1 Medical AI Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical AI Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical AI as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 AI-Integrated Hardware
3.1.2 Software
3.1.3 Services
3.2 Global Medical AI Sales Value by Type
3.2.1 Global Medical AI Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical AI Sales Value, by Type (2019-2030)
3.2.3 Global Medical AI Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Imaging and Diagnosis
4.1.2 Data Management
4.1.3 Telemedicine
4.1.4 Remote Monitoring and Lifestyle Management
4.1.5 Robot-Assisted Surgery
4.1.6 Drug Discover and Clinical Trials
4.1.7 Virtual Assistance
4.1.8 Others
4.2 Global Medical AI Sales Value by Application
4.2.1 Global Medical AI Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical AI Sales Value, by Application (2019-2030)
4.2.3 Global Medical AI Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical AI Sales Value by Region
5.1.1 Global Medical AI Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical AI Sales Value by Region (2019-2024)
5.1.3 Global Medical AI Sales Value by Region (2025-2030)
5.1.4 Global Medical AI Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical AI Sales Value, 2019-2030
5.2.2 North America Medical AI Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical AI Sales Value, 2019-2030
5.3.2 Europe Medical AI Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical AI Sales Value, 2019-2030
5.4.2 Asia Pacific Medical AI Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical AI Sales Value, 2019-2030
5.5.2 South America Medical AI Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical AI Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical AI Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical AI Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical AI Sales Value
6.3 United States
6.3.1 United States Medical AI Sales Value, 2019-2030
6.3.2 United States Medical AI Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical AI Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical AI Sales Value, 2019-2030
6.4.2 Europe Medical AI Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical AI Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical AI Sales Value, 2019-2030
6.5.2 China Medical AI Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical AI Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical AI Sales Value, 2019-2030
6.6.2 Japan Medical AI Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical AI Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical AI Sales Value, 2019-2030
6.7.2 South Korea Medical AI Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical AI Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical AI Sales Value, 2019-2030
6.8.2 Southeast Asia Medical AI Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical AI Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical AI Sales Value, 2019-2030
6.9.2 India Medical AI Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical AI Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Activ Surgical, Inc.
7.1.1 Activ Surgical, Inc. Profile
7.1.2 Activ Surgical, Inc. Main Business
7.1.3 Activ Surgical, Inc. Medical AI Products, Services and Solutions
7.1.4 Activ Surgical, Inc. Medical AI Revenue (US$ Million) & (2019-2024)
7.1.5 Activ Surgical, Inc. Recent Developments
7.2 Atomwise, Inc.
7.2.1 Atomwise, Inc. Profile
7.2.2 Atomwise, Inc. Main Business
7.2.3 Atomwise, Inc. Medical AI Products, Services and Solutions
7.2.4 Atomwise, Inc. Medical AI Revenue (US$ Million) & (2019-2024)
7.2.5 Atomwise, Inc. Recent Developments
7.3 Babylon Health
7.3.1 Babylon Health Profile
7.3.2 Babylon Health Main Business
7.3.3 Babylon Health Medical AI Products, Services and Solutions
7.3.4 Babylon Health Medical AI Revenue (US$ Million) & (2019-2024)
7.3.5 BenevolentAI Recent Developments
7.4 BenevolentAI
7.4.1 BenevolentAI Profile
7.4.2 BenevolentAI Main Business
7.4.3 BenevolentAI Medical AI Products, Services and Solutions
7.4.4 BenevolentAI Medical AI Revenue (US$ Million) & (2019-2024)
7.4.5 BenevolentAI Recent Developments
7.5 Butterfly Network, Inc.
7.5.1 Butterfly Network, Inc. Profile
7.5.2 Butterfly Network, Inc. Main Business
7.5.3 Butterfly Network, Inc. Medical AI Products, Services and Solutions
7.5.4 Butterfly Network, Inc. Medical AI Revenue (US$ Million) & (2019-2024)
7.5.5 Butterfly Network, Inc. Recent Developments
7.6 Freenome
7.6.1 Freenome Profile
7.6.2 Freenome Main Business
7.6.3 Freenome Medical AI Products, Services and Solutions
7.6.4 Freenome Medical AI Revenue (US$ Million) & (2019-2024)
7.6.5 Freenome Recent Developments
7.7 General Electric Company
7.7.1 General Electric Company Profile
7.7.2 General Electric Company Main Business
7.7.3 General Electric Company Medical AI Products, Services and Solutions
7.7.4 General Electric Company Medical AI Revenue (US$ Million) & (2019-2024)
7.7.5 General Electric Company Recent Developments
7.8 International Business Machines Corporation (IBM)
7.8.1 International Business Machines Corporation (IBM) Profile
7.8.2 International Business Machines Corporation (IBM) Main Business
7.8.3 International Business Machines Corporation (IBM) Medical AI Products, Services and Solutions
7.8.4 International Business Machines Corporation (IBM) Medical AI Revenue (US$ Million) & (2019-2024)
7.8.5 International Business Machines Corporation (IBM) Recent Developments
7.9 Koninklijke Philips N.V.
7.9.1 Koninklijke Philips N.V. Profile
7.9.2 Koninklijke Philips N.V. Main Business
7.9.3 Koninklijke Philips N.V. Medical AI Products, Services and Solutions
7.9.4 Koninklijke Philips N.V. Medical AI Revenue (US$ Million) & (2019-2024)
7.9.5 Koninklijke Philips N.V. Recent Developments
7.10 Nuance Communications, Inc.
7.10.1 Nuance Communications, Inc. Profile
7.10.2 Nuance Communications, Inc. Main Business
7.10.3 Nuance Communications, Inc. Medical AI Products, Services and Solutions
7.10.4 Nuance Communications, Inc. Medical AI Revenue (US$ Million) & (2019-2024)
7.10.5 Nuance Communications, Inc. Recent Developments
7.11 Nvidia Corporation
7.11.1 Nvidia Corporation Profile
7.11.2 Nvidia Corporation Main Business
7.11.3 Nvidia Corporation Medical AI Products, Services and Solutions
7.11.4 Nvidia Corporation Medical AI Revenue (US$ Million) & (2019-2024)
7.11.5 Nvidia Corporation Recent Developments
7.12 Olive
7.12.1 Olive Profile
7.12.2 Olive Main Business
7.12.3 Olive Medical AI Products, Services and Solutions
7.12.4 Olive Medical AI Revenue (US$ Million) & (2019-2024)
7.12.5 Olive Recent Developments
7.13 Siemens Healthineers AG
7.13.1 Siemens Healthineers AG Profile
7.13.2 Siemens Healthineers AG Main Business
7.13.3 Siemens Healthineers AG Medical AI Products, Services and Solutions
7.13.4 Siemens Healthineers AG Medical AI Revenue (US$ Million) & (2019-2024)
7.13.5 Siemens Healthineers AG Recent Developments
7.14 Viz.ai, Inc.
7.14.1 Viz.ai, Inc. Profile
7.14.2 Viz.ai, Inc. Main Business
7.14.3 Viz.ai, Inc. Medical AI Products, Services and Solutions
7.14.4 Viz.ai, Inc. Medical AI Revenue (US$ Million) & (2019-2024)
7.14.5 Viz.ai, Inc. Recent Developments
7.15 Zebra Medical Vision Ltd
7.15.1 Zebra Medical Vision Ltd Profile
7.15.2 Zebra Medical Vision Ltd Main Business
7.15.3 Zebra Medical Vision Ltd Medical AI Products, Services and Solutions
7.15.4 Zebra Medical Vision Ltd Medical AI Revenue (US$ Million) & (2019-2024)
7.15.5 Zebra Medical Vision Ltd Recent Developments
8 Industry Chain Analysis
8.1 Medical AI Industrial Chain
8.2 Medical AI Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical AI Sales Model
8.5.2 Sales Channel
8.5.3 Medical AI Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Activ Surgical, Inc.
Atomwise, Inc.
Babylon Health
BenevolentAI
Butterfly Network, Inc.
Freenome
General Electric Company
International Business Machines Corporation (IBM)
Koninklijke Philips N.V.
Nuance Communications, Inc.
Nvidia Corporation
Olive
Siemens Healthineers AG
Viz.ai, Inc.
Zebra Medical Vision Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂